Nanophase Technologies, a technology leader in nanostructured materials and nanoengineered dispersions, announces the availability of innovative nanoengineered dispersions optimized for water-based coatings.
A flagship example of the UK s ability to transform world-class research into cutting edge business, as recognized by the government organisation, UK Trade & Investment who asked Nanoco Technologies CEO, Michael Edelman to deliver a Keynote speech to an international audience at the UK NanoForum 2007 held in London on November 27, 2007.
NaturalNano, Inc. President and Chief Technology Officer Cathy Fleischer, Ph.D. will present at the Third Annual Axiom Capital Management/Livingston Nanotechnology Conference in New York City on Friday, Dec. 7, 2007.
Nanocoatings are a prime example of the application of nanotechnology making a difference in wide variety of markets from stain resistant bathrooms to improved safety in transportation. This new report is the most comprehensive yet published on this key area of nanotechnology.
One of the most active and important current areas of research and application of nanotechnology is in the field of life sciences and healthcare. Many industry and business analysts now expect nanotechnology to revolutionize the pharmaceutical, medical devices, diagnostics and imaging sectors with annual markets of billions of pounds likely within five-ten years.
The infection problems increase dramatically worldwide and affects the markets for disinfection products and systems, mainly in food and beverage preservation, pharmaceutical and chemical and water disinfection.
SEMATECH's continuing leadership in developing alternative transistor materials and processes for advanced semiconductors will be further demonstrated here next week at the 2007 IEEE International Electron Devices Meeting.
Dr. Drzaic's presentation, "Is there a Role for Silicon Microelectronics in an Increasingly-flexible World?" will take a broad view of the emergence of flexible electronic devices, and compare the potential of incumbent silicon technologies with emerging microelectronic technologies.
Arrowhead Research Corporation announced today that majority owned subsidiary, Unidym, Inc., has completed a $10.4 million Series C financing. Several financial institutions participated in the round, along with strategic investors Tokyo Electron Ventures and Battelle Memorial Institute. Arrowhead made a $3 million follow on investment.